Outcomes and complications of pelvic lymph node dissection during robotic-assisted radical prostatectomy

World Journal of Urology

Volumn 31, Issue 3, 2013, Pages 481-488

  Liss, Michael A ^a   Palazzi, Kerrin ^a   Stroup, Sean P ^b   Jabaji, Ramzi ^a   Raheem, Omer A ^a   Kane, Christopher J ^a,c  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO HEALTH SYSTEM   (United States)

^b NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

Da Vinci; Lymph node; Lymphadenectomy; Prostate cancer; Robotic

Indexed keywords

AGED; ARTICLE; COMPARATIVE STUDY; HUMAN; INCIDENCE; LAPAROSCOPY; LYMPH NODE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHOCELE; MALE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PELVIS; PROSTATE TUMOR; PROSTATECTOMY; RETROSPECTIVE STUDY; RISK FACTOR; ROBOTICS; TREATMENT OUTCOME;

AGED; HUMANS; INCIDENCE; LAPAROSCOPY; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; LYMPHOCELE; MALE; MIDDLE AGED; PELVIS; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS; ROBOTICS; TREATMENT OUTCOME;

EID: 84878220235     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-013-1056-9     Document Type: Article

References (30)

1. Messing EM, Manola J, Sarosdy M, Wilding G, Crawford ED, Trump D (1999) Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer. New Eng J Med 341: 1781-1788. doi: 10. 1056/NEJM199912093412401.
2. Wagner M, Sokoloff M, Daneshmand S (2008) The role of pelvic lymphadenectomy for prostate cancer-therapeutic? J Urol 179: 408-413. doi: 10. 1016/j. juro. 2007. 09. 027.
3. Joslyn SA, Konety BR (2006) Impact of extent of lymphadenectomy on survival after radical prostatectomy for prostate cancer. Urology 68: 121-125. doi: 10. 1016/j. urology. 2006. 01. 055.
4. McDowell GC 2nd, Johnson JW, Tenney DM, Johnson DE (1990) Pelvic lymphadenectomy for staging clinically localized prostate cancer. Indications, complications, and results in 217 cases. Urology 35: 476-482.
5. Zorn KC, Katz MH, Bernstein A, Shikanov SA, Brendler CB, Zagaja GP, Shalhav AL (2009) Pelvic lymphadenectomy during robot-assisted radical prostatectomy: assessing nodal yield, perioperative outcomes, and complications. Urology 74: 296-302. doi: 10. 1016/j. urology. 2009. 01. 077.
6. Bishoff JT, Reyes A, Thompson IM, Harris MJ, St Clair SR, Gomella L, Butzin CA (1995) Pelvic lymphadenectomy can be omitted in selected patients with carcinoma of the prostate: development of a system of patient selection. Urology 45: 270-274.
7. Roehl KA, Han M, Ramos CG, Antenor JA, Catalona WJ (2004) Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3, 478 consecutive patients: long-term results. J Urol 172: 910-914. doi: 10. 1097/01. ju. 0000134888. 22332. bb.
8. Abdollah F, Sun M, Suardi N, Gallina A, Capitanio U, Bianchi M, Tutolo M, Passoni N, Karakiewicz PI, Rigatti P, Montorsi F, Briganti A (2012) National comprehensive cancer network practice guidelines 2011: need for more accurate recommendations for pelvic lymph node dissection in prostate cancer. J Urol 188: 423-428. doi: 10. 1016/j. juro. 2012. 03. 129.
9. Bader P, Burkhard FC, Markwalder R, Studer UE (2003) Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure? J Urol 169: 849-854. doi: 10. 1097/01. ju. 0000049032. 38743. c7.
10. Hu JC, Prasad SM, Gu X, Williams SB, Lipsitz SR, Nguyen PL, Choueiri TK, Choi WW, D'Amico AV (2011) Determinants of performing radical prostatectomy pelvic lymph node dissection and the number of lymph nodes removed in elderly men. Urology 77: 402-406. doi: 10. 1016/j. urology. 2010. 05. 015.
11. Briganti A, Chun FK, Salonia A, Suardi N, Gallina A, Da Pozzo LF, Roscigno M, Zanni G, Valiquette L, Rigatti P, Montorsi F, Karakiewicz PI (2006) Complications and other surgical outcomes associated with extended pelvic lymphadenectomy in men with localized prostate cancer. Euro Urol 50: 1006-1013. doi: 10. 1016/j. eururo. 2006. 08. 015.
12. Feifer AH, Elkin EB, Lowrance WT, Denton B, Jacks L, Yee DS, Coleman JA, Laudone VP, Scardino PT, Eastham JA (2011) Temporal trends and predictors of pelvic lymph node dissection in open or minimally invasive radical prostatectomy. Cancer 117: 3933-3942. doi: 10. 1002/cncr. 25981.
13. Bader P, Burkhard FC, Markwalder R, Studer UE (2002) Is a limited lymph node dissection an adequate staging procedure for prostate cancer? J Urol 168: 514-518 discussion 518.
14. Touijer KA, Ahallal Y, Guillonneau BD (2012) Indications for and anatomical extent of pelvic lymph node dissection for prostate cancer: practice patterns of uro-oncologists in North America. Urol Oncol. doi: 10. 1016/j. urolonc. 2012. 04. 021.
15. Network NCC (2011) NCCN guidelines in oncology. Prostate Cancer (v1. 2011). http://www. nccn. org/professionals/physician_gls/f_guidelines. asp.
16. Weingartner K, Ramaswamy A, Bittinger A, Gerharz EW, Voge D, Riedmiller H (1996) Anatomical basis for pelvic lymphadenectomy in prostate cancer: results of an autopsy study and implications for the clinic. J Urol 156: 1969-1971.
17. Yee DS, Katz DJ, Godoy G, Nogueira L, Chong KT, Kaag M, Coleman JA (2010) Extended pelvic lymph node dissection in robotic-assisted radical prostatectomy: surgical technique and initial experience. Urology 75: 1199-1204. doi: 10. 1016/j. urology. 2009. 06. 103.
18. Yuh BE, Ruel NH, Mejia R, Wilson CM, Wilson TG (2012) Robotic extended pelvic lymphadenectomy for intermediate- and high-risk prostate cancer. Euro Urol 61: 1004-1010. doi: 10. 1016/j. eururo. 2012. 01. 048.
19. Mattei A, Fuechsel FG, Bhatta Dhar N, Warncke SH, Thalmann GN, Krause T, Studer UE (2008) The template of the primary lymphatic landing sites of the prostate should be revisited: results of a multimodality mapping study. Euro Urol 53: 118-125. doi: 10. 1016/j. eururo. 2007. 07. 035.
20. Capitanio U, Pellucchi F, Gallina A, Briganti A, Suardi N, Salonia A, Abdollah F, Di Trapani E, Jeldres C, Cestari A, Karakiewicz PI, Montorsi F (2011) How can we predict lymphorrhoea and clinically significant lymphocoeles after radical prostatectomy and pelvic lymphadenectomy? Clinical implications. BJU Int 107: 1095-1101. doi: 10. 1111/j. 1464-410X. 2010. 09580. x.
21. Orvieto MA, Coelho RF, Chauhan S, Palmer KJ, Rocco B, Patel VR (2011) Incidence of lymphoceles after robot-assisted pelvic lymph node dissection. BJU Int 108: 1185-1190. doi: 10. 1111/j. 1464-410X. 2011. 10094. x.
22. Heidenreich A, Bellmunt J, Bolla M, Joniau S, Mason M, Matveev V, Mottet N, Schmid HP, van der Kwast T, Wiegel T, Zattoni F (2011) EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. Euro Urol 59: 61-71. doi: 10. 1016/j. eururo. 2010. 10. 039.
23. Association AU (2007) Guideline for the management of clinically localized prostate cancer: 2007 update. http://www. auanet. org/content/guidelines-and-quality-care/clinical-guidelines/main-reports/proscan07/content. pdf.
24. Cagiannos I, Karakiewicz P, Eastham JA, Ohori M, Rabbani F, Gerigk C, Reuter V, Graefen M, Hammerer PG, Erbersdobler A, Huland H, Kupelian P, Klein E, Quinn DI, Henshall SM, Grygiel JJ, Sutherland RL, Stricker PD, Morash CG, Scardino PT, Kattan MW (2003) A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer. J Urol 170: 1798-1803. doi: 10. 1097/01. ju. 0000091805. 98960. 13.
25. Briganti A, Blute ML, Eastham JH, Graefen M, Heidenreich A, Karnes JR, Montorsi F, Studer UE (2009) Pelvic lymph node dissection in prostate cancer. Euro Urol 55: 1251-1265. doi: 10. 1016/j. eururo. 2009. 03. 012.
26. Eden CG, Arora A, Rouse P (2010) Extended vs standard pelvic lymphadenectomy during laparoscopic radical prostatectomy for intermediate- and high-risk prostate cancer. BJU Intl 106: 537-542. doi: 10. 1111/j. 1464-410X. 2009. 09161. x.
27. Heidenreich A, Varga Z, Von Knobloch R (2002) Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis. J Urol 167: 1681-1686.
28. Joniau S, van den Bergh L, Lerut E, Deroose CM, Haustermans K, Oyen R, Budiharto T, Ameye F, Bogaerts K, van Poppel H (2012) Mapping of pelvic lymph node metastases in prostate cancer. Euro Urol. doi: 10. 1016/j. eururo. 2012. 06. 057.
29. Clark T, Parekh DJ, Cookson MS, Chang SS, Smith ER Jr, Wells N, Smith JA Jr (2003) Randomized prospective evaluation of extended versus limited lymph node dissection in patients with clinically localized prostate cancer. J Urol 169: 145-147. doi: 10. 1097/01. ju. 0000039647. 16278. 17 discussion 147-148.
30. Musch M, Klevecka V, Roggenbuck U, Kroepfl D (2008) Complications of pelvic lymphadenectomy in 1, 380 patients undergoing radical retropubic prostatectomy between 1993 and 2006. J Urol 179: 923-928. doi: 10. 1016/j. juro. 2007. 10. 072 discussion 928-929.